MUC5AC and Obesity: The trial group also showed a rising trend in Rikenellaceae_RC9_gut_group, a dominant gut microbiota phylotype associated with mucin metabolism (32), negative correlation with obesity (33), carbohydrate digestion (34), and anti-inflammatory effects via suppression of pro-inflammatory cytokines (35).